Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CR1L encodes a membrane-bound inhibitor of complement activation, which contains several tandemly arranged short consensus repeats (SCRs) of approximately 60 amino acids. Additionally we are shipping Complement Component (3b/4b) Receptor 1-Like Kits (6) and Complement Component (3b/4b) Receptor 1-Like Proteins (3) and many more products for this protein.
Showing 10 out of 22 products:
CR1L transcript appears to be limited to hematopoietic and fetal lymphoid tissue.
Factor H (show CFH Antibodies) and Crry are critical for regulating complement activation at distinct anatomic sites within the kidney.
this study has provided direct evidence for a role of Crry in controlling spontaneous alternative pathway complement activation on renal tubular epithelial cells.
HBx can up-regulate CD59 (show CD59 Antibodies) and Crry expression in podocytes through activating the P38 (show CRK Antibodies) pathway.
Crry costimulation enhanced the in vitro expansion of natural Treg cells while maintaining their phenotypic and suppressive properties. Crry-expanded Treg cells decreasing antigen-dependent secretion of cytokines.
Stmn2 (show STMN2 Antibodies) and the chromosome 14 Rarb (show RARB Antibodies) region, but not Cr1 (show TDGF1 Antibodies) or Clu (show CLU Antibodies) or Picalm (show PICALM Antibodies), have roles in prion (show PRNP Antibodies) disease.
There is a significant reduction in the numbers of both neutrophils and macrophages in cardiac isografts isolated from mice treated with either complement receptor 2-Crry or CR2-factor H (show CFH Antibodies).
Crry is clearly present in the placentas from spontaneous abortions in mice.
Crry is the only membrane-bound complement regulator expressed on the basolateral surface of murine renal tubular epithelial cells under in vitro culture conditions.
Data show that a single-nucleotide polymorphism in the first short consensus repeat of Sle1c Crry introduced a novel N-linked glycosylation site likely responsible for structural alteration.
mesangial cell Crry limits complement activation and subsequent neutrophil recruitment in the setting of local immune complex deposition.
This gene encodes a membrane-bound inhibitor of complement activation, which contains several tandemly arranged short consensus repeats (SCRs) of approximately 60 amino acids. The encoded protein may play a role in tumor immune surveillance, which is unrelated to complement inhibition. Three alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.
complement component (3b/4b) receptor 1-like
, complement regulatory GPI-anchor protein
, 5I2 antigen
, Complement receptor related protein
, antigen 5I2
, complement component receptor 1-like protein
, complement receptor type 1
, complement regulatory protein Crry
, complement C4b-binding protein CR-1-like protein
, complement receptor related protein
, protein p65